These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1712132)

  • 21. The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes.
    Weaver JL; Pine PS; Aszalos A
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):179-90. PubMed ID: 7521360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
    Teutsch M; Higer M; Wang D; Wortis HW
    Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
    Dumont FJ; Kastner C; Iacovone F; Fischer PA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506.
    Li PK; Nicholls MG; Lai KN
    Adverse Drug React Acute Poisoning Rev; 1990; 9(3):123-55. PubMed ID: 1703724
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.
    Zheng B; Shorthouse R; Masek MA; Berry G; Billingham ME; Morris RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):851-5. PubMed ID: 1703717
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction.
    Smith DM; Bluestone JA; Thistlethwaite JR; Woodle ES
    Transplant Proc; 1995 Feb; 27(1):395-7. PubMed ID: 7879035
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli.
    Furue M; Ishibashi Y
    Transplantation; 1991 Sep; 52(3):522-6. PubMed ID: 1654606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.
    Flanagan WM; Corthésy B; Bram RJ; Crabtree GR
    Nature; 1991 Aug; 352(6338):803-7. PubMed ID: 1715516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell activation via cell-surface antigens other than the CD3/T cell receptor complex.
    Yokoyama WM; Shevach EM
    Year Immunol; 1989; 4():110-46. PubMed ID: 2467458
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence for a cyclosporine-resistant pathway of T cell activation triggered via the CD3/T cell receptor complex.
    Schlitt HJ; Schwinzer R; Kurrle R; Wonigeit K
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):103-9. PubMed ID: 2966472
    [No Abstract]   [Full Text] [Related]  

  • 33. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells.
    Jenkins MK; Taylor PS; Norton SD; Urdahl KB
    J Immunol; 1991 Oct; 147(8):2461-6. PubMed ID: 1717561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction.
    Bierer BE; Schreiber SL; Burakoff SJ
    Transplantation; 1990 Jun; 49(6):1168-70. PubMed ID: 1694317
    [No Abstract]   [Full Text] [Related]  

  • 36. Interleukin 1-mediated activation of interleukin 4 (IL 4)-producing T lymphocytes. Proliferation by IL 4-dependent and IL 4-independent mechanisms.
    Ho SN; Abraham RT; Nilson A; Handwerger BS; McKean DJ
    J Immunol; 1987 Sep; 139(5):1532-40. PubMed ID: 3114369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that rapamycin inhibits interleukin-12-induced proliferation of activated T lymphocytes.
    Bertagnolli MM; Yang L; Herrmann SH; Kirkman RL
    Transplantation; 1994 Nov; 58(10):1091-6. PubMed ID: 7974715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of interleukin 3 gene induction in normal human T cells.
    Guba SC; Stella G; Turka LA; June CH; Thompson CB; Emerson SG
    J Clin Invest; 1989 Dec; 84(6):1701-6. PubMed ID: 2556442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.